Metabolic and structural effects of insulin-like growth factor-I and high-protein diet on dystrophic hamster skeletal muscle

Proceedings of the Society for Experimental Biology and Medicine

Volumn 215, Issue 2, 1997, Pages 168-173

  Zdanowicz, Martin M ^a   Teichberg, Saul ^b   O'Connor, Margaret ^b   Moyse, Jeffrey ^b   Slonim, Alfred E ^b  

^a MASSACHUSETTS COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

^b NORTH SHORE UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT SOMATOMEDIN C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HAMSTER; HORMONE ACTION; MALE; MUSCLE METABOLISM; MUSCULAR DYSTROPHY; NONHUMAN; PROTEIN DEGRADATION; PROTEIN DETERMINATION; PROTEIN DIET;

ANIMALIA; CRICETINAE;

EID: 0030957105     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: 10.3181/00379727-215-44124     Document Type: Article

References (35)

1. Goldberg AI, Griffin GE, Dice JF. Regulation of protein synthesis in normal and dystrophic muscle. In: Rowland LP, Ed. Pathogenesis of Human Muscular Dystrophies. Amsterdam: Excerpta Medica, pp376-385, 1977.
2. Fulks RM, Li JB, Goldberg AL. Effects of insulin, glucose and amino acids on protein turnover in rat diaphragm. J Biol Chem 250:290-298, 1975.
3. Tawa NE, Goldberg AL. Protein and amino acid metabolism in muscle. In: Engel AG, Baker BQ, Eds. Myology. New York: McGraw-Hill, pp721-743, 1986.
4. Zdanowicz MM, Slonim AE, Bilaniuk I, O'Conner M, Moyse J, Teichberg S. High protein diet has beneficial effects in murine muscular dystrophy. J Nutr 125:1150-1158, 1995.
5. Monier S, LeMarchand-Bristel Y, Zapf J. Effects of insulin and IGF-I on RNA synthesis from isolated soleus muscle. J Mol Cell Endocrinol 37:109-114, 1984.
6. Moxley R, Arner P, Moss A, Skottner A, Fox M, James D, Livingston JN. Acute effects of insulin-like growth factor I and insulin on glucose metabolism in vivo. Am J Physiol 259:E561-E567, 1990.
7. Poggi C, LeMarchand-Bristel Y, Zapf J. Effects and binding of IGF-I in the isolated soleus of lean and obese mice, comparisons with insulin. Endocrinology 105:730-732, 1979.
8. Turkalj I, Keller U, Nirmis R, Vosmer S, Stauffacher W. Effect of increasing doses of recombinant human insulin-like growth factor on glucose, lipid and leucine metabolism in man. J Clin Endocrinol Metabol 75:1186-1191, 1992.
9. Ballard SF, Nield MK, Francis GL, Knowles SE. Regulation of intracellular protein degradation by insulin and growth factors. Acta Biol Med Ger 40:1293-1300, 1981.
10. Medina R, Wing SS, Kettelhut I, Goldberg AL. Regulation of different proteolytic systems in muscle by insulin and food intake. In: Nair KS, Ed. Protein Metabolism in Diabetes Mellitus. London: Gordon-Smith, pp111-123, 1992.
11. Kettlehut I, Wing S, Goldberg A. Endocrine regulation of protein breakdown in skeletal muscle. Diabetes Metab Rev 4:751-772, 1988.
12. Zdanowicz MM, Moyse J, Wingertzahn MA, O'Connor M, Teichberg S, Slonim AE. Effect of insulin-like growth factor I in murine muscular dystrophy. Endocrinology 136:4880-4886, 1995.
13. Ballard JF, Nield MF, Thomas FM. Effects of insulin on protein synthesis in muscles from normal and dystrophic mice. Muscle Nerve 6:520-523, 1980.
14. Li JB. Protein synthesis and degradation in skeletal muscle of normal and dystrophic hamsters. Am J Physiol 239:E401-E406, 1980.
15. Ruderman NB, Houghton S, Hems R. Evaluation of the isolated perfused rat hindquarters for the study of muscle metabolism. Biochem J 124:639-651, 1971.
16. Bylund-Fellenius A, Ojamaa K, Flaim K, Li JB, Wassner SJ, Jefferson LS. Protein synthesis versus energy state in contracting muscles of perfused rat hind limbs. Am J Physiol 246:E297-E305, 1984.
17. Dong NW, Grant JR. High speed liquid chromatographic analysis of amino acids by post-column sodium hypochlorite-o-phthaladehyde reaction. J Chromatogr 327:17-25, 1985.
18. Ribierio H, Teichberg S, McGarvey E. Quantitative alterations in the structural development of jejunal absorptive epithelial cells and their subcellular organelles in protein-energy malnourished rats: A stereologic analysis. Gastroenterology 93:1381-1392, 1987.
19. Weibel ER, Kistler GS, Scherle WF. Practical stereologic methods for morphometric cytology. J Cell Biol 30:23-28, 1966.
20. Zar JH. The normal distribution. In: Kurtz B, Ed. Biostatistical Analysis. Englewood Cliffs, NJ: Prentice Hall, pp162-183, 1984.
21. Zar JH. Multisample hypothesis: The analysis of variance. In: Kurtz B, Ed. Biostatistical Analysis. Englewood Cliffs, NJ: Prentice Hall, pp162-183, 1984.
22. Homburger F, Nixon CW, Eppendberger M, Baker JR. Hereditary myopathy in the Syrian hamster: Studies on pathogenesis. Ann N Y Acad Sci 138:14-27, 1966.
23. Crawford AJ, Bhattacharya SK. Excessive intercellular zinc accumulation in cardiac and skeletal muscle of dystrophic hamsters. Exp Neurol 95:265-276, 1987.
24. Elder GCB. Beneficial effects of exercise training on developing dystrophic muscle. Muscle Nerve 15:672-677, 1992.
25. Goldspink DF, Goldspink G. Age-related changes in protein turnover and ribonucleic acid content of diaphragm muscle of normal and dystrophic hamsters. Biochem J 162:191-194, 1977.
26. Sugden PH, Fuller SJ. Regulation of protein turnover in skeletal and cardiac muscle. Biochem J 273:21-37, 1991.
27. Baxter RC. Insulin-like growth factor (IGF) binding proteins: The role of serum IGF-BP's in regulating IGF availability. Acta Paediatr Scand 372:107-114, 1991.
28. Thissen JP, Keteslegers JM, Underwood LE. Nutritional regulation of the insulin-like growth factors. Endocr Rev 15:80-104, 1994.
29. Clemmons DR, Underwood LE. Role of insulin-like growth factors and growth hormone in reversing catabolic states. Horm Res 38:37-40, 1992.
30. Clemmons DR, Smith-Banks A, Celinker AC. Reversal of diet-induced catabolism by infusion of recombinant insulin-like growth factor I in humans. J Clin Endocrinol Metab 74:234-238, 1992.
31. Umpleby AM, Shojaee-Moradie F, Thomason MJ, Kelly JM, Skottner A, Sonksen PH, Jones RH. Effects of insulin-like growth factor I and combined insulin infusions on protein metabolism in dogs. Eur J Clin Invest 24:337-344, 1994.
32. Slonim AE, Coleman RA, Moses NS. Myopathy and growth failure in debrancher enzyme deficiency: Improvement with high protein, nocturnal enterai therapy. J Pediatr 105:906-911, 1984.
33. Slonim AE, Goans RJ. Myopathy in McArdles syndrome: Improvement with high protein therapy. N Engl J Med 312:355-359, 1985.
34. Slonim AE, Rosenthal H, Goldberg T. High protein and exercise therapy in Duchenne muscular dystrophy. Pediatr Res 27:39A, 1990.
35. Vlachopapadopaulou E, Zachwieja JJ, Gertner JM, Manzione D, Bier DM, Matthews DE, Slonim AE. Metabolic and clinical response to human insulin-like growth factor I in myotonic dystrophy - A clinical research center study. J Clin Endocrinol Metab 80:3715-3723, 1995.